NO20001747L - Doseringsform for aerosoladministrasjon - Google Patents

Doseringsform for aerosoladministrasjon

Info

Publication number
NO20001747L
NO20001747L NO20001747A NO20001747A NO20001747L NO 20001747 L NO20001747 L NO 20001747L NO 20001747 A NO20001747 A NO 20001747A NO 20001747 A NO20001747 A NO 20001747A NO 20001747 L NO20001747 L NO 20001747L
Authority
NO
Norway
Prior art keywords
drug
network
amount
aqueous vehicle
kit
Prior art date
Application number
NO20001747A
Other languages
English (en)
Other versions
NO20001747D0 (no
Inventor
Martin P Redmon
Joseph A West
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of NO20001747D0 publication Critical patent/NO20001747D0/no
Publication of NO20001747L publication Critical patent/NO20001747L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2093—Containers having several compartments for products to be mixed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/02—Sprayers or atomisers specially adapted for therapeutic purposes operated by air or other gas pressure applied to the liquid or other product to be sprayed or atomised
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/202—Separating means
    • A61J1/2041—Separating means having removable plugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/005—Sprayers or atomisers specially adapted for therapeutic purposes using ultrasonics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

En fremgangsmåte for fremstilling av aerosoler av vannsensitive medikamenter og et farmasøytisk kit for aerosoladministrasjon er beskrevet. Kitet inkluderer (a) et fast tilstand åpent matriksnettverk av et medikament i en første beholder; og en vandig vehikel i en andre beholder. Den første og den andre beholderen kan separeres eller de kan være kamre inne i et enkelt kabinett. Fast tilstand nettverket kan være en enhetsdose av et medikament og mengden av vandig vehikel vil deretter være den mengden som trengs for å levere en enhetsdose av aerosolen; alternativt kan det faste nettverket inneholde en pluralitet av enhetsdoser av medikamentet, i hvert tilfelle vil mengden av vandig vehikel være den mengden som trengs for å levere det antallet enhetsdoser i nettverket. Kitet kan også omfatte en målbar doseforstøver. Et foretrukket medikament for anvendelse i fremgangsmåten er formoterol.
NO20001747A 1997-10-08 2000-04-05 Doseringsform for aerosoladministrasjon NO20001747L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6136397P 1997-10-08 1997-10-08
PCT/US1998/021115 WO1999017754A1 (en) 1997-10-08 1998-10-07 Dosage form for aerosol administration

Publications (2)

Publication Number Publication Date
NO20001747D0 NO20001747D0 (no) 2000-04-05
NO20001747L true NO20001747L (no) 2000-04-05

Family

ID=22035318

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20001747A NO20001747L (no) 1997-10-08 2000-04-05 Doseringsform for aerosoladministrasjon

Country Status (12)

Country Link
US (1) US6161536A (no)
EP (1) EP1021172B1 (no)
JP (1) JP2001518494A (no)
KR (1) KR20010024453A (no)
AT (1) ATE215820T1 (no)
AU (1) AU743174B2 (no)
CA (1) CA2301569A1 (no)
DE (1) DE69804832T2 (no)
ES (1) ES2175799T3 (no)
HU (1) HUP0003917A3 (no)
NO (1) NO20001747L (no)
WO (1) WO1999017754A1 (no)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5758637A (en) 1995-08-31 1998-06-02 Aerogen, Inc. Liquid dispensing apparatus and methods
US6427682B1 (en) * 1995-04-05 2002-08-06 Aerogen, Inc. Methods and apparatus for aerosolizing a substance
US6040344A (en) * 1996-11-11 2000-03-21 Sepracor Inc. Formoterol process
US6679249B2 (en) * 1998-04-21 2004-01-20 Pneumoflex Systems, L.L.C. Apparatus for treatment of chronic obstructive pulmonary disease and associated method
US6235177B1 (en) 1999-09-09 2001-05-22 Aerogen, Inc. Method for the construction of an aperture plate for dispensing liquid droplets
EP1244426A4 (en) * 1999-12-23 2004-10-06 Robert E Coifman METHODS AND FORMULATIONS FOR THE EFFICIENT ADMINISTRATION OF WATER-INSOLUBLE MEDICINES BY MEANS OF A NEBULIATOR
US8336545B2 (en) 2000-05-05 2012-12-25 Novartis Pharma Ag Methods and systems for operating an aerosol generator
US7971588B2 (en) 2000-05-05 2011-07-05 Novartis Ag Methods and systems for operating an aerosol generator
US6968840B2 (en) 2000-05-05 2005-11-29 Aerogen, Inc. Methods and systems for operating an aerosol generator
US7914470B2 (en) 2001-01-12 2011-03-29 Celleration, Inc. Ultrasonic method and device for wound treatment
US8235919B2 (en) 2001-01-12 2012-08-07 Celleration, Inc. Ultrasonic method and device for wound treatment
IL156580A0 (en) 2001-01-25 2004-01-04 Bristol Myers Squibb Co A method for formulating an epothilone analog for parenteral use and pharmaceutical preparations including an epothilone analog
ITMI20010428A1 (it) * 2001-03-02 2002-09-02 Chemo Breath S A Composizioni ad uso inalatorio a base di formoterolo
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
US6667344B2 (en) * 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
EG24184A (en) 2001-06-15 2008-10-08 Otsuka Pharma Co Ltd Dry powder inhalation system for transpulmonary
WO2003026556A2 (en) * 2001-09-12 2003-04-03 Ivax Corporation Breath-enhanced ultrasonic nebulizer and dedicated unit dose ampoule
WO2003035030A1 (en) * 2001-10-24 2003-05-01 Pari Gmbh Kit for the preparation of a pharmaceutical composition
AU2003202925B2 (en) 2002-01-07 2008-12-18 Aerogen, Inc. Devices and methods for nebulizing fluids for inhalation
US7677467B2 (en) 2002-01-07 2010-03-16 Novartis Pharma Ag Methods and devices for aerosolizing medicament
AU2003256253A1 (en) 2002-05-20 2003-12-02 Aerogen, Inc. Aerosol for medical treatment and methods
US20040045546A1 (en) 2002-09-05 2004-03-11 Peirce Management, Llc Pharmaceutical delivery system for oral inhalation through nebulization consisting of inert substrate impregnated with substance (S) to be solubilized or suspended prior to use
EP1572217B1 (en) 2002-12-12 2008-08-20 Nycomed GmbH Combination medicament of r,r-formoterol and ciclesonide
US8435497B2 (en) 2003-06-13 2013-05-07 Takeda Gmbh Formoterol of and ciclesonide combination
TWI359675B (en) * 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US8616195B2 (en) 2003-07-18 2013-12-31 Novartis Ag Nebuliser for the production of aerosolized medication
WO2005097095A1 (en) * 2004-04-05 2005-10-20 Sepracor Inc. (r,r)-formoterol in combination with other pharmacological agents
US7946291B2 (en) 2004-04-20 2011-05-24 Novartis Ag Ventilation systems and methods employing aerosol generators
US8546423B2 (en) 2005-05-18 2013-10-01 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
HUE038814T2 (hu) 2005-05-18 2018-11-28 Horizon Orphan Llc Aeroszolizált fluor-kinolonok és alkalmazásaik
MX2007014867A (es) 2005-05-25 2008-02-21 Aerogen Inc Sistema y metodos de vibracion.
US7785277B2 (en) 2005-06-23 2010-08-31 Celleration, Inc. Removable applicator nozzle for ultrasound wound therapy device
US7713218B2 (en) * 2005-06-23 2010-05-11 Celleration, Inc. Removable applicator nozzle for ultrasound wound therapy device
US9101949B2 (en) 2005-08-04 2015-08-11 Eilaz Babaev Ultrasonic atomization and/or seperation system
US20080319079A1 (en) * 2005-11-23 2008-12-25 Feanny Stephen J Method for Administering Formoterol Using a Nebulizer
NZ568700A (en) 2005-11-28 2012-03-30 Marinus Pharmaceuticals Solid stabilized particulate formulations comprising ganaxolone
DE102005057685A1 (de) * 2005-12-01 2007-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalator und Speicher für eine trockene Arzneimittelformulierung sowie diesbezügliche Verfahren und Verwendung
US20080230053A1 (en) 2006-09-15 2008-09-25 Board Of Regents, The University Of Texas System Pulse drug nebulization systems, formulations therefore, and methods of use
BRPI0717721A2 (pt) * 2006-11-28 2013-10-29 Marinus Pharmaceuticals "partículas complexadas de drogas, composição farmacêutica, uso de uma composição farmacêutica, partículas complexadas de droga estabilizadas no tamanho, método para a preparação de partículas estabilizadas da droga, composição farmacêutica sólida, comprimido oral ingerível e composição líquida em nanopartículas estabilizadas no tamanho"
US8491521B2 (en) 2007-01-04 2013-07-23 Celleration, Inc. Removable multi-channel applicator nozzle
US9849254B2 (en) * 2007-05-15 2017-12-26 Caddo Medical Technologies Llc Pre-filled, small-volume nebulizer
US8597616B2 (en) 2007-10-22 2013-12-03 Board Of Regents Of The University Of Texas System Dry powder drug delivery formulations, methods of use, and devices therefore
JP2012505223A (ja) 2008-10-07 2012-03-01 エムペックス・ファーマシューティカルズ・インコーポレーテッド 薬物動態の改善のためのエアゾールフルオロキノロン配合物
CN102325532B (zh) 2008-10-07 2015-06-17 Mpex医药有限公司 用于减轻肺部炎症的左氧氟沙星吸入剂
US8534031B2 (en) * 2008-12-30 2013-09-17 Bausch & Lomb Incorporated Packaging solutions
LT2473170T (lt) 2009-09-04 2019-10-10 Horizon Orphan Llc Aerozolizuoto levofloksacino panaudojimas cistinės fibrozės gydymui
JP5494186B2 (ja) * 2010-04-28 2014-05-14 オムロンヘルスケア株式会社 ネブライザキットおよびネブライザ
AU2012212269B2 (en) 2011-01-31 2016-05-19 Avalyn Pharma Inc. Aerosol pirfenidone and pyridone analog compounds and uses thereof
GB201111250D0 (en) * 2011-07-01 2011-08-17 Univ Central Lancashire Method of producing a nebuliser composition
JP6501264B2 (ja) 2012-07-24 2019-04-17 アヴァリン ファーマ インク． エアロゾルのピルフェニドン及びピリドンのアナログの化合物、及び、その使用
US9662345B2 (en) * 2013-06-14 2017-05-30 Professional Compounding Centers Of America Antibiotic composition for inhalation and irrigation
CA3172586A1 (en) 2013-07-31 2015-02-05 Avalyn Pharma Inc. Aerosol imatininb compounds and uses thereof
WO2015080901A1 (en) 2013-11-26 2015-06-04 Celleration Inc. Systems and methods for producing and delivering ultrasonic therapies for wound treatment and healing
KR20230050474A (ko) 2016-08-11 2023-04-14 오비드 테라퓨틱스 인크. 간질 장애의 치료를 위한 방법 및 조성물
JP6853275B2 (ja) * 2016-12-05 2021-03-31 微邦科技股▲ふん▼有限公司Ｍｉｃｒｏｂａｓｅ Ｔｅｃｈｎｏｌｏｇｙ Ｃｏｒｐ． 切替え可能な部分を有するエアゾール発生装置
WO2019110099A1 (en) 2017-12-06 2019-06-13 Qrumpharma Inc. Inhalable clofazimine formulation
AU2019248020A1 (en) * 2018-04-05 2020-10-15 Royal Melbourne Institute Of Technology Multi surface acoustic nebuliser
EP3840737A1 (en) 2018-08-23 2021-06-30 MannKind Corporation Compositions of clofazimine, combinations comprising them, processes for their preparation, uses and methods comprising them
US11266662B2 (en) 2018-12-07 2022-03-08 Marinus Pharmaceuticals, Inc. Ganaxolone for use in prophylaxis and treatment of postpartum depression
US20220023282A1 (en) 2018-12-13 2022-01-27 Mannkind Corporation Compositions of Bedaquiline, Combinations Comprising Them, Processes for Their Preparation, Uses and Methods of Treatment Comprising Them
JP2023510661A (ja) 2019-06-04 2023-03-15 サーティー ホールディングス リミテッド 窒素酸化物を生成するための方法及び組成物、並びにそれらの使用
WO2020245574A1 (en) 2019-06-04 2020-12-10 Thirty Respiratory Limited Methods and compositions for generating nitric oxide and uses thereof to deliver nitric oxide via the respiratory tract
JP2022543837A (ja) 2019-08-05 2022-10-14 マリナス ファーマシューティカルズ， インコーポレイテッド てんかん重積状態の治療に使用するためのガナキソロン
JP2023503928A (ja) 2019-12-06 2023-02-01 マリナス ファーマシューティカルズ， インコーポレイテッド 結節性硬化症の治療での使用のためのガナキソロン
GB2586301B (en) 2020-04-07 2021-08-25 Splash Tm Gmbh Stable-Foam inhalation Device and Cartridge
GB2610722A (en) 2020-04-23 2023-03-15 Thirty Respiratory Ltd Nitric oxide or nitric oxide releasing compositions for use in treating SARS-COV and SARS-COV-2
GB2610721A (en) 2020-04-23 2023-03-15 Thirty Respiratory Ltd Methods and compositions for treating and combatting tuberculosis
WO2021247542A2 (en) 2020-06-01 2021-12-09 Advent Therapeutics, Inc. Pharmaceutical compositions comprising insoluble active ingredients
WO2022240897A1 (en) 2021-05-10 2022-11-17 Sepelo Therapeutics, Llc Pharmaceutical composition comprising delafloxacin for administration into the lung
WO2023028364A1 (en) 2021-08-27 2023-03-02 Sepelo Therapeutics, Llc Targeted compositions and uses therof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3898338A (en) * 1971-10-07 1975-08-05 Mead Johnson & Co 1,4-Bis-acylpiperazine mucolytic process
IE45770B1 (en) * 1976-10-06 1982-11-17 Wyeth John & Brother Ltd Pharmaceutical dosage forms
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
US4194640A (en) * 1977-05-06 1980-03-25 The Upjohn Company Vial and closure
US4089432A (en) * 1977-05-06 1978-05-16 The Upjohn Company Vial and closure
US4274543A (en) * 1978-01-23 1981-06-23 The Upjohn Company Vial and closure structure
US4267925A (en) * 1979-10-01 1981-05-19 The Upjohn Company Closure for large-volume vial
US4258845A (en) * 1979-11-20 1981-03-31 The Upjohn Company Activator closure for two-compartment vial
US4331233A (en) * 1980-05-30 1982-05-25 The Upjohn Company Activation closure for vial
KR100256147B1 (ko) * 1991-12-24 2000-08-01 오노다 마사요시 구강내 붕해성 제제 및 이의 제조방법
US5215079A (en) * 1992-05-19 1993-06-01 Armstrong Pharmaceuticals, Inc. Single dose metered dose inhaler for delivery of vaccines and other drugs
US5586550A (en) * 1995-08-31 1996-12-24 Fluid Propulsion Technologies, Inc. Apparatus and methods for the delivery of therapeutic liquids to the respiratory system
AU2322097A (en) * 1996-03-27 1997-10-17 Ortho Pharmaceutical Corporation Lyophilized pulmonary surfactant peptide compositions

Also Published As

Publication number Publication date
HUP0003917A3 (en) 2001-04-28
DE69804832T2 (de) 2002-11-07
JP2001518494A (ja) 2001-10-16
AU9687998A (en) 1999-04-27
HUP0003917A2 (en) 2001-03-28
ATE215820T1 (de) 2002-04-15
EP1021172B1 (en) 2002-04-10
CA2301569A1 (en) 1999-04-15
NO20001747D0 (no) 2000-04-05
EP1021172A1 (en) 2000-07-26
KR20010024453A (ko) 2001-03-26
DE69804832D1 (de) 2002-05-16
US6161536A (en) 2000-12-19
AU743174B2 (en) 2002-01-17
WO1999017754A1 (en) 1999-04-15
ES2175799T3 (es) 2002-11-16

Similar Documents

Publication Publication Date Title
NO20001747L (no) Doseringsform for aerosoladministrasjon
WO2003035137A3 (en) Method and apparatus for dispensing inhalator medicament
CA2112674A1 (en) Method and device for delivering aerosolized medicaments
CA2309155A1 (en) A method and apparatus for dosing a medical preparation
IE792155L (en) Medicament container
EP1078628A3 (en) Multiple unit tableted dosage form
AU1534699A (en) Osmotic dosage form comprising first and second coats
CA2240329A1 (en) Improved delivery of multiple doses of medications
AU7792987A (en) Administration and dosage form for drug active agents, reagents or the like and process for the preparation thereof
DE69530079D1 (de) Vorrichtung zur verabreichung von einzelnen gaben eines medikaments
EP1388337A3 (en) Pharmaceutical dispenser system
AU2084801A (en) Antiviral medication
IL108071A0 (en) Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridines their preparation and pharmaceutical compositions containing them
DE69602759T2 (de) Pharmazeutische zusammensetzungen und vorrichtungen zu deren verabreichung
WO2002024261A3 (en) Shock wave aerosolization apparatus and method
Murray Evaluation of aspirin in treatment of headache
BRPI0413374A (pt) composições para liberação de base fraca por um perìodo estendido de tempo
MX9304931A (es) Anticonceptivos que contienen antiprogestogenos.
DE59503283D1 (de) Carbamazepin-arzneiform mit verzögerter wirkstofffreisetzung
EA200301128A1 (ru) Однократная доза ингибитора ароматазы для лечения бесплодия
US3891749A (en) Digestive pharmaceutical composition comprising S-carboxymethyl cysteine for reducing viscosity of respiratory tract secretions, and method of treating therewith
DE69830997D1 (de) Pharmazeutische zusammensetzungen, die schwerlösliche arzneistoffe enthalten
RU94457U1 (ru) Упаковка суточной дозы лекарственных препаратов перорального применения для комплексной медикаментозной терапии (варианты) и упаковка лекарственных препаратов перорального применения для курса комплексной медикаментозной терапии
GB2397763A (en) Method of dispensing pharmaceutical substances
Wechsler COVID-19 VACCINE MAKERS OVERCOME CHALLENGES TO RAMP UP PRODUCTION

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application